Chemoinformaics analysis of HEXACOSYL (E)-3-(4-HYDROXY-3-METHOXYPHENYL)PROP-2-ENOATE
| Molecular Weight | 558.888 | nRot | 28 |
| Heavy Atom Molecular Weight | 496.392 | nRig | 27 |
| Exact Molecular Weight | 558.465 | nRing | 1 |
| Solubility: LogS | -2.746 | nHRing | 0 |
| Solubility: LogP | 3.74 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 102 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 62 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 104.669 |
| nHD | 1 | BPOL | 66.5388 |
| QED | 0.647 |
| Synth | 3.986 |
| Natural Product Likeliness | 1.219 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.721 |
| Pgp-sub | 0.287 |
| HIA | 0.005 |
| CACO-2 | -5.171 |
| MDCK | 0.00000879 |
| BBB | 0.489 |
| PPB | 0.812431 |
| VDSS | 1.913 |
| FU | 0.0964665 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.925 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.232 |
| CYP2d6-inh | 0.436 |
| CYP2d6-sub | 0.947 |
| CYP3a4-inh | 0.092 |
| CYP3a4-sub | 0.928 |
| CL | 8 |
| T12 | 0.52 |
| hERG | 0.929 |
| Ames | 0.066 |
| ROA | 0.322 |
| SkinSen | 0.433 |
| Carcinogencity | 0.018 |
| EI | 0.006 |
| Respiratory | 0.763 |
| NR-Aromatase | 0.121 |
| Antiviral | No |
| Prediction | 0.615106 |